In another study using anti-carbonic anhydrase IX (CAIX) CAR-T cells against GBM patient-derived stem cells that were intracranially inoculated in NSG mice, a 20% cure rate was detected and without GBM, recurrent 2 months post-treatment [127]. Here, CA9 is linked to glioblastoma.